Generative AI has made it easier than ever to simulate audience reactions. But as more pharma teams embrace synthetic audience testing, the question isn’t can we do it, it’s are we doing it in a way ...

ZUG, Switzerland and BELLEVUE, Washington , Oct. 23, 2025 (GLOBE NEWSWIRE) -- aXedras, the pioneering provider of digital ...

Life sciences organizations are facing both intense pressure and extraordinary opportunity, according to Mark Sullivan, president of regulated industries at Salesforce. In a conversation with The Top ...

On Thursday evening, President Donald Trump announced new efforts to expand access to IVF, which includes a deal with EMD Serono, a subsidiary of the Germany-based pharmaceutical company Merck KGaA, ...

The pharmaceutical world offers a valuable blueprint on how to harness AI’s efficiency while protecting trust, ethics and above all, people.

AI has the potential to transform life sciences commercialization, but only if we design it around people. Machines bring ...

As the global healthcare industry sprints toward smarter, personalised innovation, new technologies are reshaping pharma at an unprecedented pace. The healthcare AI opportunity alone is projected to ...

In the UK, there was a case where TGN1412, an immunotherapy under development, triggered a cytokine storm within hours of ...

State privacy laws are reshaping the way pharmaceutical companies reach patients, said Katie Carr, chief revenue officer at Swoop, in a conversation with Fierce Pharma Publisher Rebecca Willumson.

Eva-Maria Hempe, NVIDIA, says AI collaboration optimizes life science research via routine automation, freeing human experts for complex strategy, ethics, and exploring scarce data. In this part 3 of ...

Judge Pauline Newman has served with distinction on the U.S. Court of Appeals for the Federal Circuit since her appointment ...